Cho, Byoung Chul - Severance Biomedical Science Institute;Yuhan-Yonsei Lung Cancer Clinical and Translational Medicine Center;Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine;Lung Cancer Center, Yonsei Cancer Center, Yonsei University College of Medicine

基本信息

Career Trajectory

Bio

2006 The Best Resident Award
(Yonsei University College of Medicine)
2008 Woo-Hyun Research Award
2008 Korean Cancer Research Foundation Award
2011 The Best Professor Award
(Severance Hospital, Yonsei University College of Medicine)
2011 Bowon Research Award

Research Interests

Papers共 1397 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Durvalumab with or Without Tremelimumab in Combination with Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes from the Phase 3 POSEIDON Trial

Solange Peters,Byoung Chul Cho,Alexander V. Luft,Jorge Alatorre-Alexander,Sarayut Lucien Geater,Konstantin Laktionov,Dmytro Trukhin,Sang-We Kim, Grygorii M. Ursol,Maen Hussein,Farah Louise Lim,Cheng-Ta Yang,Luiz Henrique Araujo,Haruhiro Saito,Niels Reinmuth, Caitlin Lowery,Helen Mann,Ross Stewart,Haiyi Jiang,Edward B. Garon

Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer (2024)

Cited0Views0WOSBibtex

Successful Expansion and Cryopreservation of Human Natural Killer Cell Line NK-92 for Clinical Manufacturing

Seul Lee,Yunjoo Joo,Eun Ji Lee,Youngseon Byeon,Jae-Hwan Kim,Kyoung-Ho Pyo,Young Seob Kim,Sun Min Lim,Peter Kilbride, Rohin K. Iyer, Mingming Li, Mandy C. French, Jung-Yub Lee,Jeeheon Kang, Hyesin Byun,Byoung Chul Cho

PLOS ONE（2024）

Cited0Views0WOSBibtex

494P Landscape of MET Activating Alterations (meta) in Advanced Cancers (AC) Using Circulating Tumor DNA (ctdna) Next-Generation Sequencing (NGS) in Asia and the Middle East (AME)

B.C. Cho, N. Peled, B-C. Ahn,S. Dawood, C-M. Tsai, S. Khandelwal, N. Sandhir, S. Olsen

Annals of Oncology (2024): S1585

Cited0Views0Bibtex

Patient-reported Outcomes in CodeBreak 200: Sotorasib Versus Docetaxel for Previously Treated Advanced NSCLC with KRAS G12C Mutation

David M. Waterhouse,Sacha Rothschild,Christophe Dooms,Bertrand Mennecier,Farastuk Bozorgmehr,Margarita Majem, Michel H. van den Heuvel,Helena Linardou,Byoung Chul Cho,Rachel Roberts-Thomson,Kentaro Tanaka,Normand Blais,Gustavo Schvartsman,Karin Holmskov Hansen,Izabela Chmielewska,Martin D. Forster,Christina Giannopoulou, Bjorn Stollenwerk, Cynthia C. Obiozor, Yang Wang,Silvia Novello

Lung Cancer（2024）

Cited0Views0WOSBibtex

A Phase 1 Study of Fianlimab (Anti-Lag-3) in Combination with Cemiplimab (Anti-Pd-1) in Patients with Advanced Ccrcc

Byoung Chul Cho,Omid Hamid, Xinhua Zhu,Bhumsuk Keam,John M. Kaczmar, Stephen K. Williamson, Ariel E. Birnbaum,Afshin Dowlati, Grace K. Dy, Steven Jeffrey Hager, Filipa Lynce,Raymond S. McDermott,Debashis Sarker,Amy M. Weise,Timothy A. Yap,Emrullah Yilmaz, Fang,Jayakumar Mani, Glenn Scott Kroog,Kyriakos P. Papadopoulos

Journal of Clinical Oncologyno. 4_suppl (2024): 434-434

Cited0Views0Bibtex

Abstract 3483: SIRT7 as a potential therapeutic target for drug resistance in lung adenocarcinoma: Insights from histone modification-related genes

Kyoung-Ho Pyo,YoungJoon Park, Gang-Taik Lee,Juwon Ahn,Su-Jin Choi, Qi Kejia, Taeku Lee,Youngtaek Kim,Joon Yeon Hwang,Byoung Chul Cho

Cancer Researchno. 6_Supplement (2024): 3483-3483

Cited0Views0Bibtex

Canakinumab in Combination with Docetaxel Compared with Docetaxel Alone for the Treatment of Advanced Non-Small Cell Lung Cancer Following Platinum-Based Doublet Chemotherapy and Immunotherapy (CANOPY-2): A Multicenter, Randomized, Double-Blind, Phase 3 Trial

Luis Paz -Ares,Yasushi Goto,Darren Wan-Teck Lim,Balazs Halmos,Byoung Chul Cho,Manuel Cobo,Jose Luis Gonzalez Larriba, Caicun Zhou,Ingel Demedts,Akin Atmaca,Sofia Baka,Bijoyesh Mookerjee,Socorro Portella,Zewen Zhu,Jincheng Wu,David Demanse,Bharani Dharan,Martin Reck

Lung Cancer (2024): 107451-107451

Cited0Views0WOSBibtex

BLU-945, a Potent and Selective Next-Generation EGFR TKI, Has Antitumor Activity in Models of Osimertinib-Resistant Non-Small-cell Lung Cancer

Sun Min Lim,Stefanie S. Schalm,Eun Ji Lee,Sewon Park,Chiara Conti,Yves A. Millet,Rich Woessner,Zhuo Zhang, Luz E. Tavera-Mendoza,Faith Stevison,Faris Albayya,Thomas A. Dineen,John Hsieh,Seung Yeon Oh,Alena Zalutskaya,Julia Rotow,Koichi Goto,Dae-Ho Lee,Mi Ran Yun,Byoung Chul Cho

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2024)

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn